Skip to navigation Skip to content

Growth hormone deficiency - paediatric patients Program in Pharmaceutical Benefits Scheme (PBS) 012-63030010

This document outlines details about PBS-subsidised somatrogon and somatropin under the section 100 Growth Hormone (GH) Program for paediatric patients with severe growth hormone deficiency.

Growth Hormone (GH) Program (paediatric use) quick reference

Table 1

Restrictions	Authority level and section	PA assessment	Processing system	Prescriber type	Prescriber self-serve
Initial PB162 form	Written Electronic S100: somatrogon somatropin	Yes	OPA	Must be treated by a: specialist or consultant physician in paediatric endocrinology, or specialist or consultant physician in general paediatrics in consultation with a nominated specialist or consultant physician in paediatric endocrinology	Yes
Continuing PB163 form	Written Electronic S100: somatrogon somatropin	Yes	OPA	Not specified	Yes
Continuing as reclassified PB164 Form	Written Electronic S100: somatrogon somatropin	Yes	OPA	Must be treated by a: medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics	Yes
Change (only for SSSG or BGHD) PB165 form	Written Electronic S100: somatrogon somatropin	Yes	OPA	Must be treated by a: specialist or consultant physician in paediatric endocrinology, or specialist or consultant physician in general paediatrics in consultation with a nominated specialist or consultant physician in paediatric endocrinology	Yes
Recommencement PB165 form	Written Electronic S100: somatrogon somatropin	Yes	OPA	Must be treated by a: medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics	Yes
Recommencement as reclassified PB166 form	Written Electronic S100: somatrogon somatropin	Yes	OPA	Must be treated by a: medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics	Yes
Grandfather PB339 form	Written Electronic S100: somatrogon	Yes	OPA	Must be treated by a: medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics	Yes